Therefore, ROS activated the CaMKII/ERK1/2 signaling pathway involved both in VILI and CLP‐induced acute lung injury, targeting ROS with quercetin not only prevented high MV‐induced lung injury but also attenuated existing inflammation‐induced lung injury. This evidence concerns the gene CAMK2G and injury.